Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» M&A
M&A
Shire bags a quick thumbs up for its newly won cancer drug pipeline
Endpoints
Mon, 07/25/16 - 11:15 am
Shire
Baxalta
M&A
Onivyde
Six Major Biotech Acquisitions You Could See in 2016 (Part 2)
Forbes
Mon, 07/25/16 - 09:51 am
biotech
M&A
Pfizer
Teva Pharmaceutical
Allergan
Shire
Portola Pharmaceuticals
Sanofi
Medivation
Regeneron
Biogen
Biogen (BIIB) Stock Up on CEO Transition, Fueling Sale Speculation
TheStreet.com
Sat, 07/23/16 - 10:28 am
Biogen
M&A
George Scangos
DOJ's Attempt To Block Two Healthcare Mergers Reflects Its Aggressive Antitrust Enforcement
Forbes
Fri, 07/22/16 - 09:32 am
DOJ
antitrust
M&A
Cigna
Anthem
Aetna
Humana
Mylan gets 'all clear' from EU regulators for $7.2 billion Meda deal
BioPharma Dive
Thu, 07/21/16 - 09:20 pm
Mylan Labs
Europe
Meda
M&A
Six Major Biotech Acquisitions You Could See in 2016 (Part 1 of 3)
Forbes
Thu, 07/21/16 - 09:29 am
biotech
M&A
Merck
Gilead Sciences
Kite Pharma
Medivation
Galenica to Buy Relypsa for $1.53 Billion
TheStreet.com
Thu, 07/21/16 - 09:05 am
Galenica
Relypsa
M&A
Veltassa
Abbott's Alere Deal Continues To Face Uncertainty
TheStreet.com
Thu, 07/21/16 - 08:55 am
Abbott Labs
Alere
M&A
devices
Will Perrigo be Gobbled Up In Consumer Health Consolidation?
Bidness, ETC
Sun, 07/17/16 - 11:03 am
Perrigo
Reckitt Benckiser
consumer health
M&A
JNJ
P&G
Juno buys Redox for combo amid ongoing trial hold fallout
Fierce Biotech
Fri, 07/15/16 - 10:36 am
Juno Therapeutics
Redox
M&A
Alere recall may further complicate fraught proposed merger with Abbott Labs
Bizjournals.com
Thu, 07/14/16 - 07:25 pm
Alere
M&A
Abbott Labs
diagnostics
Shire Could Divest ADHD Treatment, Other Assets, for More Upside Post-Baxalta
TheStreet.com
Thu, 07/14/16 - 07:21 pm
Shire
ADHD
Baxalta
Brexit
M&A
Vyvanse
Teva, Allergan generics deal to close 'at any time now'
BioPharma Dive
Thu, 07/14/16 - 10:08 am
Teva Pharmaceutical
generics
M&A
Allergan
Teva Pharm to raise $20-$25 bln in bond sale next week -report
Yahoo/Reuters
Thu, 07/14/16 - 09:13 am
Teva Pharmaceutical
Allergan
M&A
generics
bonds
A Look at Jazz Pharmaceuticals’ Celator Acquisition Deal
Market Realist
Thu, 07/14/16 - 09:10 am
Jazz Pharmaceuticals
Celator
M&A
Medivation Inc: A Takeover Can Fetch Higher Sales
Bidness, ETC
Wed, 07/13/16 - 11:03 am
Medivation
M&A
Sanofi
AstraZeneca
Celgene
Pfizer
Gilead Sciences
Teva Climbs as Vigodman Sees No Delay to Deal With Allergan
Bloomberg
Wed, 07/13/16 - 09:45 am
Teva Pharmaceutical
Erez Vigodman
Allergan
generics
M&A
FTC seeks more info on Abbott-St. Jude deal
Yahoo/Reuters
Tue, 07/12/16 - 06:59 pm
FTC
devices
Abbott Labs
St. Jude Medical
M&A
AstraZeneca considering $10-billion offer for Medivation: report
First Word Pharma
Mon, 07/11/16 - 11:27 am
AstraZeneca
Medivation
M&A
Sanofi
Why BioMarin's Shares Tumbled 11% in June
Motley Fool
Sun, 07/10/16 - 12:09 pm
Biomarin
M&A
Duchenne Muscular Dystrophy
Sanofi
drisapersen
Kyndrisa
Pages
« first
‹ previous
…
122
123
124
125
126
127
128
129
130
…
next ›
last »